The Role of Peroxisome Proliferator-Activated Receptor γ in Immune Responses to Enteroaggregative Escherichia coli Infection

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Philipson, Casandra W ^a,b   Bassaganya Riera, Josep ^a,b,c   Viladomiu, Monica ^a,b   Pedragosa, Mireia ^a,b   Guerrant, Richard L ^d   Roche, James K ^d   Hontecillas, Raquel ^a,b  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; ENTEROAGGREGATIVE ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE EXPRESSION REGULATION; GROWTH RETARDATION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALNUTRITION; MOLECULAR MODEL; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH17 CELL; UPREGULATION; WEIGHT REDUCTION;

ANILIDES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; BODY WEIGHT; CELL PROLIFERATION; DISEASE PROGRESSION; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; INTERLEUKIN-17; INTESTINAL MUCOSA; MALNUTRITION; MICE; MICE, INBRED C57BL; PPAR GAMMA; T-LYMPHOCYTES; TIME FACTORS;

EID: 84874565215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057812     Document Type: Article

References (64)

1. Cennimo D, Abbas A, Huang DB, Chiang T, (2009) The prevalence and virulence characteristics of enteroaggregative Escherichia coli at an urgent-care clinic in the USA: a case-control study. J Med Microbiol 58: 403-407.
2. Weintraub A, (2007) Enteroaggregative Escherichia coli: epidemiology, virulence and detection. J Med Microbiol 56: 4-8.
3. Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, et al. (2001) Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 32: 1706-1709.
4. Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR, (2011) Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis 15: e136-139.
5. Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, et al. (2006) Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis 43: 556-563.
6. Katona P, Katona-Apte J, (2008) The interaction between nutrition and infection. Clin Infect Dis 46: 1582-1588.
7. Guerrant RL, Oria RB, Moore SR, Oria MO, Lima AA, (2008) Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 66: 487-505.
8. Rodriguez L, Cervantes E, Ortiz R, (2011) Malnutrition and gastrointestinal and respiratory infections in children: a public health problem. Int J Environ Res Public Health 8: 1174-1205.
9. Hughes S, Kelly P, (2006) Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunol 28: 577-588.
10. Nataro JP, Kaper JB, (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
11. Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD, (2011) Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One 6: e27030.
12. Strauman MC, Harper JM, Harrington SM, Boll EJ, Nataro JP, (2010) Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect Immun 78: 4958-4964.
13. Steiner TS, Nataro JP, Poteet-Smith CE, Smith JA, Guerrant RL, (2000) Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest 105: 1769-1777.
14. Khan MA, Kang J, Steiner TS, (2004) Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology 112: 651-660.
15. Fleckenstein JM, Kopecko DJ, (2001) Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens. J Clin Invest 107: 27-30.
16. Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, et al. (2012) Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol 14: 120-132.
17. Delerive P, Fruchart JC, Staels B, (2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169: 453-459.
18. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, et al. (2002) Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640-6650.
19. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, et al. (2004) Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791.
20. Henderson RB, Hobbs JA, Mathies M, Hogg N, (2003) Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102: 328-335.
21. Murray J, Barbara JA, Dunkley SA, Lopez AF, Van Ostade X, et al. (1997) Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783.
22. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI, (1991) Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477.
23. Cooper AM, (2009) IL-17 and anti-bacterial immunity: protection versus tissue damage. Eur J Immunol 39: 649-652.
24. Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y, (2007) Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178: 4466-4472.
25. Kouhkan A, Pourpak Z, Moin M, Dorosty AR, Safaralizadeh R, et al. (2004) A study of malnutrition in Iranian patients with primary antibody deficiency. Iran J Allergy Asthma Immunol 3: 189-196.
26. Chandra RK, (1997) Nutrition and the immune system: an introduction. Am J Clin Nutr 66: 460S-463S.
27. Al Jarousha AM, El Jarou MA, El Qouqa IA, (2011) Bacterial enteropathogens and risk factors associated with childhood diarrhea. Indian J Pediatr 78: 165-170.
28. Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, et al. (2006) Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55: 1104-1113.
29. Chinetti G, Fruchart JC, Staels B, (2000) Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflammation Research 49: 497-505.
30. Hontecillas R, Bassaganya-Riera J, (2007) Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J Immunol 178: 2940-2949.
31. Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, et al. (2008) Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology 134: 688-695.
32. Hedges S, Svensson M, Svanborg C, (1992) Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 60: 1295-1301.
33. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95: 55-65.
34. Lim JH, Um HJ, Park JW, Lee IK, Kwon TK, (2009) Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways. Exp Mol Med 41: 757-764.
35. Jarchum I, Liu M, Shi C, Equinda M, Pamer EG, (2012) Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 80: 2989-2996.
36. Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, et al. (2012) IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 209: 1595-1609.
37. de Luca C, Olefsky JM, (2008) Inflammation and insulin resistance. FEBS Lett 582: 97-105.
38. Sibartie S, O'Hara AM, Ryan J, Fanning A, O'Mahony J, et al. (2009) Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol 10: 54.
39. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, et al. (2000) CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495-503.
40. Williams IR, (2006) CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann N Y Acad Sci 1072: 52-61.
41. Kim TG, Byamba D, Wu WH, Lee MG, (2011) Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment. Exp Dermatol 20: 855-857.
42. Tak PP, Firestein GS, (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11.
43. Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, et al. (2012) Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol 12: 5.
44. Shastri YM, Bergis D, Povse N, Schafer V, Shastri S, et al. (2008) Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med 121: 1099-1106.
45. Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y, (2007) Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 45: 414-420.
46. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.
47. Hamza T, Barnett JB, Li B, (2010) Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 11: 789-806.
48. Ogawa H, Mukai K, Kawano Y, Minegishi Y, Karasuyama H, (2012) Th2-inducing cytokines IL-4 and IL-33 synergistically elicit the expression of transmembrane TNF-alpha on macrophages through the autocrine action of IL-6. Biochem Biophys Res Commun 420: 114-118.
49. Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, et al. (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169: 443-453.
50. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
51. Takahashi N, Vanlaere I, de Rycke R, Cauwels A, Joosten LA, et al. (2008) IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 205: 1755-1761.
52. Michel ML, Keller AC, Paget C, Fujio M, Trottein F, et al. (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204: 995-1001.
53. Mrabet-Dahbi S, Metz M, Dudeck A, Zuberbier T, Maurer M, (2009) Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol 18: 437-444.
54. Song C, Luo L, Lei Z, Li B, Liang Z, et al. (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181: 6117-6124.
55. Li L, Huang L, Vergis AL, Ye H, Bajwa A, et al. (2010) IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120: 331-342.
56. Cua DJ, Tato CM, (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479-489.
57. Curtis MM, Way SS, (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
58. Peck A, Mellins ED, (2010) Precarious balance: Th17 cells in host defense. Infect Immun 78: 32-38.
59. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279.
60. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, et al. (2011) Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17: 837-844.
61. Wang C, Kang SG, Lee J, Sun Z, Kim CH, (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2: 173-183.
62. Rubino SJ, Geddes K, Girardin SE, (2012) Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 33: 112-118.
63. Manel N, Unutmaz D, Littman DR, (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: 641-649.
64. Jiang ZD, Okhuysen PC, Guo DC, He R, King TM, et al. (2003) Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 188: 506-511.